Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

GlaxoSmithKline Consumer Healthcare Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (126)

Date

2021 (19)
2020 (55)
2019 (6)
2018 (34)
2017 (12)

Results for "[search-keyword]"

Search

Sponsor content

126 result(s) found, displaying 31 to 40

NICABATE SOFT GUM MINT nicotine 2mg chewing gum blister pack Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE SOFT GUM MINT nicotine 4mg chewing gum blister pack Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
LAMISIL JOCK ITCH DERMGEL terbinafine 10mg/g tube Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE CQ MINT LOZENGE nicotine 2mg tube Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE CQ MINT LOZENGE nicotine 4mg tube Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
ALLI orlistat 120mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE PRE-QUIT nicotine 21 mg/24 hours Clear Patch transdermal drug delivery sachet Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
SUVACID HEARTBURN RELIEF pantoprazole (as sodium sesquihydrate) 20 mg enteric coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
VOLTAREN RAPID 25 LIQUID CAPSULE diclofenac potassium 25 mg soft capsule blister pack Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE MINIS CHERRY nicotine 1.5mg lozenge tube Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.